Daicel Corporation
Daicel Corporation (DACHF) Revenue
Annual & quarterly revenue history · segment & region breakdown
DACHF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDaicel Corporation trailing twelve-month (TTM) revenue is $583B, a decrease of 0.55% year-over-year from $583B in FY2026.
Revenue trend
2026 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $583B | -$3.25B | -0.55% |
| 2025-03-31 | $587B | +$28.48B | +5.10% |
| 2024-03-31 | $558B | +$20.03B | +3.72% |
| 2023-03-31 | $538B | +$70.09B | +14.98% |
| 2022-03-31 | $468B | +$74.37B | +18.90% |
| 2021-03-31 | $394B | -$19.26B | -4.66% |
| 2020-03-31 | $413B | -$52.03B | -11.19% |
| 2019-03-31 | $465B | +$1.90B | +0.41% |
| 2018-03-31 | $463B | +$22.89B | +5.20% |
| 2017-03-31 | $440B | -$9.82B | -2.18% |
Compare revenue vs peers
Chemicals - SpecialtyCompare DACHF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Daicel Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Daicel Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in JPY.
Data sourced from Daicel Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DACHF revenue · 4 questionsDACHF's trailing twelve-month (TTM) revenue is $583B. That is a decrease of 0.55% year-over-year from $583B in FY2026.
▸ Source: FMP · Daicel Corporation SEC filings · GAAP · Daicel Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026